MarkForrestGordonMD

Neurology • Great Neck, NY

Director, Clinical Development and Medical Affairs, General Medicine / Central Nervous Systems

Join to view full profile

Dr. Gordon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gordon's full profile

Already have an account?

Office
865 Northern Blvd
Great Neck, NY 11021
Phone+1 516-570-4477

Fax+1 516-465-1890

Education & Training

Stony Brook Medicine/University HospitalResidency, Neurology, 1986 - 1990
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1985 - 1986
Perelman School of Medicine at the University of PennsylvaniaClass of 1985

Certifications & Licensure

NY State Medical License 1986 - 2025
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease.
Samuel Frank, Claudia M Testa, Jody Goldstein, Elise Kayson, Blair R Leavitt
CNS Drugs. 2025-02-01
Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Samuel Frank, Karen E Anderson, Hubert H Fernandez, Robert A Hauser, Daniel O Claassen
Neurology and Therapy. 2024-12-01
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the ...
Robert A Hauser, Hadas Barkay, Hubert H Fernandez, Joohi Jimenez-Shahed, Stewart A Factor
Journal of Clinical Psychopharmacology. 2024-06-21

Press Mentions

Causes of Depression Brain InjuryAugust 6th, 2017